Financials

  • Market Capitalization 734.9 M
  • Employee 55
  • Founded 2003
  • CEO N/A
  • Website www.candeltx.com
  • Headquarter Delaware, United States
  • FIGI BBG00N0D4Z71
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.85
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2637
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.50 USD+0.48%-0.12%+24.85%+37.74%767.84 M USD
2649
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.58 USD-2.07%-9.87%-23.05%-17.70%752.72 M USD
2666
AURA
Aura Biosciences, Inc. - Common Stock
7.10 USD+1.43%+1.43%+9.57%+4.41%734.04 M USD
2686
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.92 USD+4.69%+7.34%+14.36%-6.01%714.56 M USD

Noticias